April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Influence of Oral 7-Methylxanthine on Lens-induced and Form Deprivation Myopia in Chickens
Author Affiliations & Notes
  • Kai Wang
    Ophthalmology Department, Peking University People's Hospital, Beijing, China
    Wildsoet Lab, School of Optometry, University of California, Berkeley, Albany, CA
  • Diane Nava
    Wildsoet Lab, School of Optometry, University of California, Berkeley, Albany, CA
  • Klaus Trier
    Trier Research Laboratories, Hellerup, Denmark
  • Christine Wildsoet
    Wildsoet Lab, School of Optometry, University of California, Berkeley, Albany, CA
  • Footnotes
    Commercial Relationships Kai Wang, None; Diane Nava, None; Klaus Trier, None; Christine Wildsoet, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3040. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kai Wang, Diane Nava, Klaus Trier, Christine Wildsoet; Influence of Oral 7-Methylxanthine on Lens-induced and Form Deprivation Myopia in Chickens. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3040.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

7-methylxanthine (7-MX), a non-selective adenosine antagonist, is approved as an anti-myopia oral medication in Denmark. To learn more about its mechanisms, this study examined its ability to inhibit lens-induced (LIM) and form deprivation myopia (FDM) in young chickens.

 
Methods
 

Forty-five young White-Leghorn chickens were divided into four groups, groups 1 and 2 being assigned -10 D lenses (n=10 each), and groups 3 and 4, white diffusers (n=12 & 13 resp.). All optical treatments were monocular, applied to left eyes, starting eight days after hatching, and extending for 10 days. From the beginning of the treatment period, groups 2 and 4 received at 9 am and 3 pm each day, two doses of oral 7-MX (30 mg/kg, samples provided by K Trier). Sterile distilled water was used as the diluent, with xanthan-gum added to ensure uniform suspension of 7-MX. Control groups (1 and 3) received the xanthan-gum solution without 7-MX, with the dosing schedule as per 7-MX. Baseline refractive errors and axial ocular dimensions were measured before treatments, using static retinoscopy and high frequency A-scan ultrasonography respectively, and measurements were repeated every other day thereafter.

 
Results
 

7-MX had a small inhibitory effect on LIM but no effect on FDM, as reflected in the refractions recorded at the end (LIM: -6.43 ± 1.30 D, 7-MX versus control, -8.30 ± 1.53 D; FDM: -10.19 ± 7.89 D, 7-MX versus -10.77 ± 7.20 D, control)(Figure 1). For LIM groups, the interocular difference in optical length was smaller in the 7-MX group. And final intergroup difference (0.12 mm) was mainly of a product of differences in anterior chamber depth (0.11 mm). Both groups showing similar interocular differences in other key ocular parameters (vitreous chamber depth and lens thickness). No significant intergroup differences in these parameters were noted for the FDM groups.

 
Conclusions
 

For the dose tested, 7-MX showed only a weak inhibitory effect against LIM and no effect against FDM in the chicken. This result adds weight to evidence suggesting a scleral site of action for the anti-myopia effect of 7-MX, because unlike mammalian and primate eyes, avian eyes have an additional cartilage layer, which largely determines eye size.

 
 
Figure 1. Interocular changes in mean spherical equivalent refractive error (SER), normalized to baseline values, for the lens-wearing group (LIM, A) and form deprived groups (FDM, B).
 
Figure 1. Interocular changes in mean spherical equivalent refractive error (SER), normalized to baseline values, for the lens-wearing group (LIM, A) and form deprived groups (FDM, B).
 
Keywords: 605 myopia • 503 drug toxicity/drug effects  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×